South China vaccine is a wholly owned subsidiary of guangzhou anjie biomedical technology co., LTD. And the first hospital affiliated to guangdong pharmaceutical university and Sydney university of science and technology work together to carry out for non small cell lung cancer, prostate cancer cells immunotherapy clinical trials, and has set up a successful registration in the ClinicalTrial, specific see the related reports：

http://www.anjiebiomed.com/index.php?_m=mod_article&_a=article_content&article_id=114